Literature DB >> 3572962

Rational design of 4-[(methylsulfonyl)amino]benzamides as class III antiarrhythmic agents.

W C Lumma, R A Wohl, D D Davey, T M Argentieri, R J DeVita, R P Gomez, V K Jain, A J Marisca, T K Morgan, H J Reiser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3572962     DOI： 10.1021/jm00388a001

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  4 in total

1.  Actions and mechanisms of action of novel analogues of sotalol on guinea-pig and rabbit ventricular cells.

Authors:  S P Connors; E W Gill; D A Terrar
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

Review 2.  A prolonged QTc interval. Is it an important effect of antiarrhythmic drugs?

Authors:  F A Fish; D M Roden
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Nov-Dec

3.  Antiarrhythmic peptide has no direct cardiac actions.

Authors:  T Argentieri; E Cantor; J R Wiggins
Journal:  Experientia       Date:  1989-08-15

4.  Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker.

Authors:  G N Beatch; S Abraham; B A MacLeod; N R Yoshida; M J Walker
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.